IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PATIENTS WITH VASCULITIS RECEIVING STANDARD OF CARE THERAPY AND CONTROLS

被引：0
|
作者：
Nived, P. [1 ]
Nagel, J. [1 ]
Saxne, T. [1 ]
Geborek, P. [1 ]
Jonsson, G. [1 ]
Skattum, L. [1 ]
Kapetanovic, M. C. [1 ]
机构：
[1] Lund Univ, Lund, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0386
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [41] Invasive pneumococcal disease after implementation of 13-valent pneumococcal conjugate vaccine
    Kyprianidou, S-A.
    Mejbri, M.
    Tornay, A. A.
    Natterer, J.
    Greub, G.
    Crisinel, P-A.
    Asner, S.
    SWISS MEDICAL WEEKLY, 2014, 144 : 42S - 43S
  • [42] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2021, 9 (10)
  • [43] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
    Olarte, Liset
    Barson, William J.
    Barson, Ryan M.
    Lin, Philana Ling
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Bradley, John S.
    Hoffman, Jill A.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 767 - 775
  • [44] Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children
    Chapoutot, A. G.
    Dessein, R.
    Guilluy, O.
    Lagree, M.
    Wallet, F.
    Varon, E.
    Martinot, A.
    Dubos, F.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (03): : 607 - 611
  • [45] Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Peterson, James T.
    Stacey, Helen L.
    MacNair, John E.
    Li, Jianing
    Hartzel, Jonathan S.
    Sterling, Tina M.
    Benner, Patrice
    Tamms, Gretchen M.
    Musey, Luwy K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 540 - 548
  • [46] IMMUNOGENICITY AND SAFETY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH ROUTINE PEDIATRIC VACCINES TO INFANTS IN KOREA
    Lee, H. J.
    Shin, S. H.
    Kim, D. S.
    Hong, Y. J.
    Lee, S. Y.
    Choi, K. M.
    Juergens, C.
    Patterson, S.
    Giardina, P.
    Gruber, W.
    Emini, E.
    Scott, D.
    ACTA PAEDIATRICA, 2010, 99 : 84 - 84
  • [47] The Antibody Response Following a Booster With Either a 10-or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy
    Truck, Johannes
    Jawad, Sena
    Goldblatt, David
    Roalfe, Lucy
    Snape, Matthew D.
    Voysey, Merryn
    Pollard, Andrew J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (07) : 787 - 793
  • [48] Immunogenicity of 13-valent pneumococcal conjugated vaccine in pediatric patients with inflammatory bowel disease
    Banaszkiewicz, A.
    Targonska, B.
    Kowalska-Duplaga, K.
    Karolewska-Bochenek, K.
    Sieczkowska, A.
    Gawronska, A.
    Grzybowska-Chlebowczyk, U.
    Krzesiek, E.
    Lazowska-Przeorek, I.
    Kotowska, M.
    Sienkiewicz, E.
    Walkowiak, J.
    Gregorek, H.
    Radzikowski, A.
    Albrecht, P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S223 - S223
  • [49] Comments about the article: "Impact of the 13-valent pneumococcal conjugate vaccine"
    Panattieri, Nestor D.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2016, 114 (06): : E486 - E486
  • [50] Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology
    Zhao, Alice S.
    Boyle, Sean
    Butrymowicz, Anna
    Engle, Robert D.
    Roberts, Jason M.
    Mouzakes, Jason
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (03) : 499 - 503
12345